Abstract | OBJECTIVE: The purpose of this study was to estimate the outcomes of uterine embolization and hysterectomy for uterine leiomyomas. Study design This was a multicenter prospective study of patients who were treated with embolization (n=102 patients) and hysterectomy (n=50 patients) for leiomyomas. Changes in symptoms, complications, and quality of life were measured. The data analysis included linear and logistic regression, the Student t and paired t test, Fisher's exact test, and chi-squared test. RESULTS: For patients who underwent embolization, there were marked reductions in blood loss scores (P <.001) and menorrhagia questionnaire scores (P <.001) compared with baseline. At 12 months, a larger proportion of the patients who had undergone hysterectomy experienced improved pelvic pain (P=.021). Both groups had marked improvement in other symptoms and quality of life scores, with no difference between groups. Complications were more frequent in patients who underwent hysterectomy (50% vs 27.5%; P=.01). CONCLUSION: Both procedures substantially improved symptoms for most patients, with an advantage for hysterectomy at 12 months for pelvic pain. Serious complications were infrequent in both groups.
|
Authors | James B Spies, Jay M Cooper, Robert Worthington-Kirsch, John C Lipman, Benjie B Mills, James F Benenati |
Journal | American journal of obstetrics and gynecology
(Am J Obstet Gynecol)
Vol. 191
Issue 1
Pg. 22-31
(Jul 2004)
ISSN: 0002-9378 [Print] United States |
PMID | 15295340
(Publication Type: Clinical Trial, Clinical Trial, Phase II, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
|
Topics |
- Adult
- Arteries
- Embolization, Therapeutic
(adverse effects)
- Female
- Health Status Indicators
- Humans
- Hysterectomy
(adverse effects)
- Leiomyoma
(blood supply, surgery, therapy)
- Logistic Models
- Microspheres
- Middle Aged
- Quality of Life
- Treatment Outcome
- Uterine Neoplasms
(blood supply, surgery, therapy)
- Uterus
(blood supply)
|